I am a
Home I AM A Search Login

Papers of the Week


2021


Front Immunol


12

Treatment of Chronic Venous Ulcers With Heterologous Fibrin Sealant: A Phase I/II Clinical Trial.

Authors

Abbade LPF, Barraviera S R C S, Silvares M R C, de Lima A BBCO, Haddad GR, Gatti MAN, Medolago N B, Rigotto Carneiro M T, Dos Santos L D, Ferreira R S, Barraviera B
Front Immunol. 2021; 12:627541.
PMID: 33708219.

Abstract

Heterologous fibrin sealant (HFS) consists of a fibrinogen-rich cryoprecipitate extracted from buffalo blood and a thrombin-like enzyme purified from snake venom. This study evaluated the safety and immunogenicity of HFS, estimated the best dose, and assessed its preliminary efficacy in the treatment of chronic venous ulcers (CVU).